Description
An ACC1/2 inhibitor and PPARα/δ agonist; has anti-obesity and antidiabetic activity and increases energy expenditure in DIO mouse models; reduces hepatic fibrosis and inflammation in a mouse model of MASLD; enhances body weight reduction and glucose control in combination with tirzepatide in DIO mice